Study 1 | Group 1 | Group 2 | Group 3 |
---|---|---|---|
TG/HDL-C < 1.60 ( N  = 2,229) | 1.60 ≤ TG/HDL-C < 2.97 ( N  = 2,202) | TG/HDL-C ≥ 2.97 ( N  = 2,129) | |
Renal function decline, n (%) | 208 (9.33) | 223 (10.13) | 217 (10.19) |
Unadjusted, OR (95 % CI) | ref. | 1.09 (0.90, 1.34) | 1.10 (0.90, 1.35) |
P | Â | 0.37 | 0.34 |
Age and gender adjusted, OR (95 % CI) | ref. | 1.19 (0.97, 1.46) | 1.29 (1.05, 1.59) |
P | Â | 0.09 | 0.02 |
a Multivariable-adjusted, OR (95 % CI) | ref. | 1.27 (1.01, 1.59) | 1.30 (1.03, 1.65) |
P | Â | 0.04 | 0.03 |